Literature DB >> 9038658

Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis.

Y Yasunaga1, Y Shinomura, S Kanayama, Y Higashimoto, M Yabu, Y Miyazaki, S Kondo, Y Murayama, H Nishibayashi, S Kitamura, Y Matsuzawa.   

Abstract

BACKGROUND AND AIMS: It has been reported that eradication of Helicobacter pylori improves fold width in H pylori associated enlarged fold gastritis. The aim of this study was to clarify the mechanism of fold thickening in this condition. PATIENTS AND METHODS: In eight patients with enlarged fold gastritis and 13 patients without enlarged folds, the presence of H pylori infection, inflammatory infiltrates, mucosal plasia, and epithelial cell proliferation in the body mucosa were investigated, and production of transforming growth factor alpha (TGF alpha), hepatocyte growth factor (HGF), and interleukin 1 beta (IL 1 beta) was determined by a competitive reverse transcription/polymerase chain reaction method and in vitro short-term culture of biopsy specimens.
RESULTS: In the patients with enlarged fold gastritis, inflammatory infiltrates including macrophages increased with H pylori colonisation in the body. Foveolar thickness and proliferating cell nuclear antigen (PCNA) labelling index were increased. Messenger RNA levels of HGF, but not TGF alpha, were increased, and release of HGF and IL 1 beta was increased. HGF release, which was positively correlated with IL 1 beta release and foveolar thickness, decreased in the presence of IL 1 receptor antagonist. After eradication of H pylori, inflammatory infiltrates, IL 1 beta and HGF release decreased with concomitant decreases in PCNA labelling index, foveolar thickness and fold width.
CONCLUSIONS: Increased IL 1 beta and HGF production caused by H pylori infection may contribute to fold thickening of the stomach by stimulating epithelial cell proliferation and foveolar hyperplasia in patients with enlarged fold gastritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9038658      PMCID: PMC1383448          DOI: 10.1136/gut.39.6.787

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Practical significance of gastric rugal folds.

Authors:  A J Press
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-09

2.  Lymphocytic gastritis and giant gastric folds associated with gastrointestinal protein loss.

Authors:  R A Wolber; D A Owen; F H Anderson; H J Freeman
Journal:  Mod Pathol       Date:  1991-01       Impact factor: 7.842

3.  Ultrastructural location of human hepatocyte growth factor in human liver.

Authors:  H Sakaguchi; S Seki; H Tsubouchi; Y Daikuhara; Y Niitani; K Kobayashi
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

4.  Determination of histidine decarboxylase mRNA in various rat tissues by the polymerase chain reaction.

Authors:  S Kondo; I Imamura; Y Shinomura; Y Matsuzawa; H Fukui
Journal:  Inflamm Res       Date:  1995-03       Impact factor: 4.575

5.  Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa.

Authors:  S Kondo; Y Shinomura; S Kanayama; Y Higashimoto; T Kiyohara; Y Yasunaga; S Kitamura; H Ueyama; I Imamura; H Fukui
Journal:  Biochem Biophys Res Commun       Date:  1995-05-25       Impact factor: 3.575

6.  Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; M Yabu; T Nakanishi; Y Miyazaki; Y Murayama; J J Bonilla-Palacios; Y Matsuzawa
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

7.  Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation.

Authors:  A G Fraser; R Sim; E A Sankey; A P Dhillon; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1994-04       Impact factor: 8.171

8.  Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture.

Authors:  M Takahashi; S Ota; T Shimada; E Hamada; T Kawabe; T Okudaira; M Matsumura; N Kaneko; A Terano; T Nakamura
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach.

Authors:  M Stolte; C H Bätz; E Bayerdörffer; S Eidt
Journal:  Z Gastroenterol       Date:  1995-04       Impact factor: 2.000

10.  Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy.

Authors:  C Avunduk; F Navab; F Hampf; B Coughlin
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864

View more
  20 in total

1.  Landscaper seeks remunerative position.

Authors:  R J Playford
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?

Authors:  W M Wong; R J Playford; N A Wright
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  Advanced gastric cancer associated with nodular gastritis in a young patient.

Authors:  Kenichiro Imai; Atsushi Mitsunaga; Tatsuo Araida; Shunsuke Onizawa; Yuurin Shin; Masayuki Nakano
Journal:  Clin J Gastroenterol       Date:  2009-06-10

5.  Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism.

Authors:  Carlos Resende; Gonçalo Regalo; Cecília Durães; Marta Teixeira Pinto; Xiaogang Wen; Ceu Figueiredo; Fátima Carneiro; José C Machado
Journal:  Gastric Cancer       Date:  2015-03-05       Impact factor: 7.370

6.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

7.  Keratinocyte growth factor and coeliac disease.

Authors:  V M Salvati; M Bajaj-Elliott; R Poulsom; G Mazzarella; K E Lundin; E M Nilsen; R Troncone; T T MacDonald
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

8.  Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases.

Authors:  Takeshi Ishikawa; Takashi Ando; Hiroshi Obayashi; Nami Nakabe; Mika Okita; Yutaka Isozaki; Yasuyuki Nagao; Hirokazu Oyamada; Yoshihiro Nakajima; Haruki Kato; Satoshi Kokura; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

9.  Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.

Authors:  Feng Ji; Zi-Wei Wang; Jian-Wen Ning; Qun-Yan Wang; Jian-Yong Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

10.  Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis.

Authors:  Daisuke Asaoka; Akihito Nagahara; Masako Oguro; Yuko Izumi; Akihiko Kurosawa; Taro Osada; Masato Kawabe; Mariko Hojo; Michiro Otaka; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.